Published in J Physiol on March 01, 1992
Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy. Am J Cardiol (2010) 1.41
Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart. J Physiol (2001) 0.97
Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis (1999) 0.92
Measurement of vascular tone and stroke volume baroreflex gain. Psychophysiology (2011) 0.82
Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart (1996) 0.82
Immediate and Complex Cardiovascular Adaptation to an Acute Alcohol Dose. Alcohol Clin Exp Res (2015) 0.78
Blood Pressure in Healthy Humans Is Regulated by Neuronal NO Synthase. Hypertension (2017) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res (1969) 5.27
Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (1989) 3.13
Systemic arterial baroreceptor reflexes. Physiol Rev (1976) 2.64
Determination of cardiac output by Doppler echocardiography. Br Heart J (1984) 2.31
Regulation of ventricular contraction by the carotid sinus. Its effect on atrial and ventricular dynamics. Circ Res (1960) 1.87
Circulatory effects of stimulating the carotid arterial stretch receptors in man at rest and during exercise. J Clin Invest (1966) 1.86
Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res (1972) 1.71
Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest (1969) 1.52
Carotid sinus baroreceptor control of splanchnic resistance and capacity. Am J Physiol (1988) 1.42
Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation (1969) 1.38
Variable effects of changes in flow rate through the aortic, pulmonary and mitral valves on valve area and flow velocity: impact on quantitative Doppler flow calculations. J Am Coll Cardiol (1985) 1.17
Role of the venous system in baroreceptor-mediated reflexes in man. J Clin Invest (1968) 1.07
Control of blood pressure by carotid sinus baroreceptors in human beings. Am J Cardiol (1979) 1.06
Cardiovascular responses to changes in carotid sinus transmural pressure in man. Acta Physiol Scand (1975) 1.03
Direct positive inotropic effect of acetylcholine on myocardium. Evidence for multiple cholinergic receptors in the heart. Circ Res (1966) 0.99
Extent of carotid sinus regulation of the myocardial contractile state in conscious dogs. J Clin Invest (1972) 0.97
Doppler ultrasonic measurement of cardiac output: reproducibility and validation. Eur Heart J (1990) 0.96
Importance of the carotid sinus baroreceptors in the regulation of myocardial performance. J Clin Invest (1971) 0.91
Carotid baroreflex resetting during drug-induced arterial pressure changes in humans. Am J Physiol (1989) 0.86
Influence of age on sensitivity and effector mechanisms of the carotid baroreflex. Acta Physiol Scand (1977) 0.84
Baroreflex control of myocardial contractility in conscious normotensive and renal hypertensive rabbits. Hypertension (1984) 0.83
Arterial pressure and pulse interval responses to repetitive carotid baroreceptor stimuli in man. J Physiol (1979) 0.82
Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography. Proc Natl Acad Sci U S A (1985) 0.81
Vagal stimulation decreases rate of left ventricular relaxation. Am J Physiol (1989) 0.81
Carotid sinus baroreceptor reflex control and epinephrine. Influence on capacitive and resistive properties of the total pulmonary vascular bed of the dog. Circ Res (1982) 0.81
Differing mechanisms of exercise flow augmentation at the mitral and aortic valves. Circulation (1988) 0.81
Effects of pulse frequency on single-unit baroreceptor activity during sine-wave and natural pulses in dogs. J Physiol (1988) 0.80
Doppler ultrasound signal analysis based on the TMS320 signal processor. J Biomed Eng (1988) 0.80
Hemodynamics of the carotid sinus reflex elicited by bilateral carotid occlusion in the conscious dog. Effect of - or -adrenergic blockade on the reflex response. Pflugers Arch (1971) 0.79
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science (1988) 5.29
Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res (1969) 5.27
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J (2000) 4.99
Transforming healthcare: a safety imperative. Qual Saf Health Care (2009) 4.87
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation (2001) 3.96
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation (1992) 3.56
Oxford and McKinsey: Cogwheel and beyond. Br Med J (1970) 3.50
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
The endotoxin-lipoprotein hypothesis. Lancet (2000) 3.03
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res (1971) 2.95
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2000) 2.85
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation (2007) 2.76
Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J (1998) 2.73
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet (2003) 2.64
Effects of physical training in chronic heart failure. Lancet (1990) 2.54
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Knowledge and communication difficulties for patients with chronic heart failure: qualitative study. BMJ (2000) 2.47
Properties of a water-soluble, yellow protein isolated from a halophilic phototrophic bacterium that has photochemical activity analogous to sensory rhodopsin. Biochemistry (1987) 2.43
Diminished baroreflex sensitivity in high blood pressure. Circulation (1969) 2.40
Isolation and characterization of soluble cytochromes, ferredoxins and other chromophoric proteins from the halophilic phototrophic bacterium Ectothiorhodospira halophila. Biochim Biophys Acta (1985) 2.35
Screening for hypertrophic cardiomyopathy. BMJ (1993) 2.31
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1997) 2.27
Candida endocarditis treated with 5-fluorocytosine. Br Med J (1971) 2.20
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Measurement and global analysis of the absorbance changes in the photocycle of the photoactive yellow protein from Ectothiorhodospira halophila. Biophys J (1994) 2.18
Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet (1981) 2.18
Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension (2001) 2.15
New perspectives on c-type cytochromes. Adv Protein Chem (1982) 2.14
Cytochrome c2 sequence variation among the recognised species of purple nonsulphur photosynthetic bacteria. Nature (1979) 2.13
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. BMJ (2001) 2.08
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J (2000) 2.06
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? Br J Obstet Gynaecol (1993) 2.04
Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet (1980) 2.00
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. BMJ (1995) 1.99
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Action potentials in fibres from receptors in the epicardium and myocardium of the dog's left ventricle. J Physiol (1965) 1.95
Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man. Br Med J (1972) 1.91
Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension (1988) 1.90
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J (2004) 1.90
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation (1996) 1.88
Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 1.87
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol (2000) 1.79
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol (2001) 1.79
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart. Am J Physiol (1999) 1.74
Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation (2000) 1.72
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res (1972) 1.71
Evidence against use of bacterial amino acid sequence data for construction of all-inclusive phylogenetic trees. Proc Natl Acad Sci U S A (1986) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J (2000) 1.66
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Early rehabilitation after myocardial infarction. Lancet (1982) 1.60
Active site mutants implicate key residues for control of color and light cycle kinetics of photoactive yellow protein. Biochemistry (1997) 1.59
New photocycle intermediates in the photoactive yellow protein from Ectothiorhodospira halophila: picosecond transient absorption spectroscopy. Biophys J (1998) 1.59
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med (1997) 1.58
Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension. Lancet (1991) 1.58
Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br Med J (Clin Res Ed) (1981) 1.58
Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non-musicians: the importance of silence. Heart (2005) 1.58
Cardiovascular and respiratory changes during sleep in normal and hypertensive subjects. Cardiovasc Res (1969) 1.57
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil (1974) 1.56
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J (1997) 1.55
The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J (1984) 1.55
Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. Eur Heart J (1995) 1.50
"Pixie" cardiography. Accelerometer applications to phonocardiography and displacement cardiography in childhood. Br Heart J (1971) 1.48
Heart Failure 99 -- the MOXCON story. Int J Cardiol (1999) 1.48
Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J (2001) 1.47
Crystallographic structure of a photoreceptor protein at 2.4 A resolution. Proc Natl Acad Sci U S A (1989) 1.45
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J (1999) 1.44
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure. Lancet (1995) 1.42
Angiotensin-converting enzyme inhibition and physical training in heart failure. J Intern Med (1991) 1.42